Report cover image

Special Coagulation Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Publisher GlobalData
Published Jun 30, 2023
Length 46 Pages
SKU # GBDT18089815

Description

Special Coagulation Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Special Coagulation Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Special Coagulation Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

These are reagents which are used to conduct special coagulation tests which provide quantitative determination of anticoagulant activities of heparin and thrombin formation.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Special Coagulation Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Special Coagulation Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Special Coagulation Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

46 Pages
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Special Coagulation Tests Overview
4 Products under Development
4.1 Special Coagulation Tests - Pipeline Products by Stage of Development
4.2 Special Coagulation Tests - Pipeline Products by Territory
4.3 Special Coagulation Tests - Pipeline Products by Regulatory Path
4.4 Special Coagulation Tests - Pipeline Products by Estimated Approval Date
5 Special Coagulation Tests - Pipeline Products under Development by Companies
5.1 Special Coagulation Tests Companies - Pipeline Products by Stage of Development
5.2 Special Coagulation Tests – Companies Pipeline Products by Stage of Development
6 Special Coagulation Tests Companies and Product Overview
6.1 Diagnostica Stago Inc Company Overview
6.1.1 Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 Helena Laboratories Corp Company Overview
6.2.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
6.3 Instrumentation Laboratory Co Company Overview
6.3.1 Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview
6.4 Massachusetts General Hospital Company Overview
6.4.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
6.5 Roche Diagnostics International Ltd Company Overview
6.5.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.6 Siemens Healthcare Diagnostics GmbH Company Overview
6.6.1 Siemens Healthcare Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
6.7 Siemens Healthcare Diagnostics Inc Company Overview
6.7.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.8 SQI Diagnostics Inc Company Overview
6.8.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
7 Special Coagulation Tests- Recent Developments
7.1 May 30, 2023: SQI Diagnostics reports second quarter 2023 results
7.2 Aug 29, 2022: SQI Diagnostics Reports Third Quarter 2022 Results
7.3 Jul 25, 2022: Beckman Coulter partners with Mass General and BARDA to identify severe pediatric infections in emergency departments
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Special Coagulation Tests - Pipeline Products by Stage of Development
Table 2: Special Coagulation Tests - Pipeline Products by Territory
Table 3: Special Coagulation Tests - Pipeline Products by Regulatory Path
Table 4: Special Coagulation Tests - Pipeline Products by Estimated Approval Date
Table 5: Special Coagulation Tests Companies - Pipeline Products by Stage of Development
Table 6: Special Coagulation Tests – Companies Pipeline Products by Stage of Development
Table 7: Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 8: STA Compact Max - NeoPTimal ISI - Product Status
Table 9: STA Compact Max - NeoPTimal ISI - Product Description
Table 10: STA Compact Max - Ristocetin Cofactor Assay - Product Status
Table 11: STA Compact Max - Ristocetin Cofactor Assay - Product Description
Table 12: STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Status
Table 13: STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Description
Table 14: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Status
Table 15: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Description
Table 16: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Status
Table 17: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Description
Table 18: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status
Table 19: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description
Table 20: STA-R Max - NeoPTimal ISI - Product Status
Table 21: STA-R Max - NeoPTimal ISI - Product Description
Table 22: STA-R Max - Ristocetin Cofactor Assay - Product Status
Table 23: STA-R Max - Ristocetin Cofactor Assay - Product Description
Table 24: STA-R Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Status
Table 25: STA-R Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Description
Table 26: Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Actalyke Mini II - LMWH Test - Product Status
Table 28: Actalyke Mini II - LMWH Test - Product Description
Table 29: Actalyke XL - Heparin Test - Product Status
Table 30: Actalyke XL - Heparin Test - Product Description
Table 31: Actalyke XL - LMWH Test - Product Status
Table 32: Actalyke XL - LMWH Test - Product Description
Table 33: Cascade M - DRVVT Test - Product Status
Table 34: Cascade M - DRVVT Test - Product Description
Table 35: Cascade M-4 - DRVVT Test - Product Status
Table 36: Cascade M-4 - DRVVT Test - Product Description
Table 37: Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview
Table 38: ACL AcuStar - VWF: RCo Assay - Product Status
Table 39: ACL AcuStar - VWF: RCo Assay - Product Description
Table 40: ACL TOP 300 CTS System - Global Protein C Pathway Test - Product Status
Table 41: ACL TOP 300 CTS System - Global Protein C Pathway Test - Product Description
Table 42: ACL TOP 500 CTS System - Global Protein C Pathway Test - Product Status
Table 43: ACL TOP 500 CTS System - Global Protein C Pathway Test - Product Description
Table 44: ACL TOP 700 System - Global Protein C Pathway Test - Product Status
Table 45: ACL TOP 700 System - Global Protein C Pathway Test - Product Description
Table 46: HemosIL ACL AcuStar - VWF:Ag Assay - Product Status
Table 47: HemosIL ACL AcuStar - VWF:Ag Assay - Product Description
Table 48: HemosIL VWF-Ristocetin Cofactor Activity Assay - Product Status
Table 49: HemosIL VWF-Ristocetin Cofactor Activity Assay - Product Description
Table 50: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 51: High Throughput Screening Assay - Fibrin-Binding Probes - Product Status
Table 52: High Throughput Screening Assay - Fibrin-Binding Probes - Product Description
Table 53: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Cobas t 511 Coagulation Analyzer - dRVVT Confirm Assay - Product Status
Table 55: Cobas t 511 Coagulation Analyzer - dRVVT Confirm Assay - Product Description
Table 56: Cobas t 511 Coagulation Analyzer - dRVVT Screen Assay - Product Status
Table 57: Cobas t 511 Coagulation Analyzer - dRVVT Screen Assay - Product Description
Table 58: Cobas t 711 Coagulation Analyzer - dRVVT Confirm Assay - Product Status
Table 59: Cobas t 711 Coagulation Analyzer - dRVVT Confirm Assay - Product Description
Table 60: Cobas t 711 Coagulation Analyzer - dRVVT Screen Assay - Product Status
Table 61: Cobas t 711 Coagulation Analyzer - dRVVT Screen Assay - Product Description
Table 62: Siemens Healthcare Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Atellica COAG 360 System - Berichrom C-1 Inhibitor Assay - Product Status
Table 64: Atellica COAG 360 System - Berichrom C-1 Inhibitor Assay - Product Description
Table 65: INNOVANCE DTI Assay - Product Status
Table 66: INNOVANCE DTI Assay - Product Description
Table 67: Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Sysmex CS-2500 System - Von Willebrand Factor Test - Product Status
Table 69: Sysmex CS-2500 System - Von Willebrand Factor Test - Product Description
Table 70: Sysmex CS-5100 System - Von Willebrand Factor Assay - Product Status
Table 71: Sysmex CS-5100 System - Von Willebrand Factor Assay - Product Description
Table 72: SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: IgXPlex - HIT Assay - Product Status
Table 74: IgXPlex - HIT Assay - Product Description
Table 75: Glossary
2.2 List of Figures
Figure 1: Special Coagulation Tests - Pipeline Products by Stage of Development
Figure 2: Special Coagulation Tests - Pipeline Products by Territory
Figure 3: Special Coagulation Tests - Pipeline Products by Regulatory Path
Figure 4: Special Coagulation Tests - Pipeline Products by Estimated Approval Date

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us